A dual‐specific anti‐IGF‐1/IGF‐2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma
Tóm tắt
The insulin‐like growth factors (IGFs), IGF‐1 and IGF‐2, have been implicated in the growth, survival and metastasis of a broad range of malignancies including pediatric tumors. They bind to the IGF receptor type 1 (IGF‐1R) and the insulin receptor (IR) which are overexpressed in many types of solid malignancies. Activation of the IR by IGF‐2 results in increased survival of tumor cells. We have previously identified a novel human monoclonal antibody, m708.5, which binds with high (pM) affinity to both human IGF‐1 and IGF‐2, and potently inhibits phosphorylation of the IGF‐1R and the IR in tumor cells. m708.5 exhibited strong antitumor activity as a single agent against most cell lines derived from neuroblastoma, Ewing family of tumor, rhabdomyosarcoma and osteosarcoma. When tested in neuroblastoma cell lines, it showed strong synergy with temsirolimus and synergy with chemotherapeutic agents
Từ khóa
Tài liệu tham khảo
DupontJ LeRoithD.Insulin and insulin‐like growth factor I receptors: similarities and differences in signal transduction.Horm Res2001;55(Suppl2):22–6.
Matsumoto K, 1994, Signals transduced via insulin‐like growth factor I receptor (IGF(R)) mediate resistance to retinoic acid‐induced cell growth arrest in a human neuroblastoma cell line, Cell Death Differ, 1, 49